BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35331907)

  • 1. GABA
    Kaushik I; Srivastava SK
    Mol Ther; 2022 Jul; 30(7):2584-2602. PubMed ID: 35331907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SALL4 is a CRL3
    Lospinoso Severini L; Loricchio E; Navacci S; Basili I; Alfonsi R; Bernardi F; Moretti M; Conenna M; Cucinotta A; Coni S; Petroni M; De Smaele E; Giannini G; Maroder M; Canettieri G; Mastronuzzi A; Guardavaccaro D; Ayrault O; Infante P; Bufalieri F; Di Marcotullio L
    Cell Death Differ; 2024 Feb; 31(2):170-187. PubMed ID: 38062245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of human glioma-associated oncogene 1 on Ser937 regulates Sonic Hedgehog signaling in medulloblastoma.
    Zeng LH; Tang C; Yao M; He Q; Qv M; Ren Q; Xu Y; Shen T; Gu W; Xu C; Zou C; Ji X; Wu X; Wang J
    Nat Commun; 2024 Feb; 15(1):987. PubMed ID: 38307877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes.
    Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY
    J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncanonical activation of GLI signaling in SOX2
    Swiderska-Syn M; Mir-Pedrol J; Oles A; Schleuger O; Salvador AD; Greiner SM; Seward C; Yang F; Babcock BR; Shen C; Wynn DT; Sanchez-Mejias A; Gershon TR; Martin V; McCrea HJ; Lindsey KG; Krieg C; Rodriguez-Blanco J
    Sci Adv; 2022 Jul; 8(29):eabj9138. PubMed ID: 35857834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma.
    Hwang GH; Pazyra-Murphy MF; Seo HS; Dhe-Paganon S; Stopka SA; DiPiazza M; Sutter N; Gero TW; Volkert A; Ombelets L; Dittemore G; Rees MG; Ronan MM; Roth JA; Agar NYR; Scott DA; Segal RA
    Cancer Res; 2024 Mar; 84(6):872-886. PubMed ID: 38486486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor.
    Wang S; Zhang D; Wang J; Peng X; Sun H; Ji Y; Yang Z; Bian X; Hou Y; Ge M; Liu Y
    J Neurooncol; 2024 May; 168(1):139-149. PubMed ID: 38662151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.
    Robinson GW; Orr BA; Wu G; Gururangan S; Lin T; Qaddoumi I; Packer RJ; Goldman S; Prados MD; Desjardins A; Chintagumpala M; Takebe N; Kaste SC; Rusch M; Allen SJ; Onar-Thomas A; Stewart CF; Fouladi M; Boyett JM; Gilbertson RJ; Curran T; Ellison DW; Gajjar A
    J Clin Oncol; 2015 Aug; 33(24):2646-54. PubMed ID: 26169613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis.
    Zhou H; Wang YX; Wu M; Lan X; Xiang D; Cai R; Ma Q; Miao J; Fang X; Wang J; Luo D; He Z; Cui Y; Liang P; Wang Y; Bian XW
    J Pathol; 2024 Apr; 262(4):427-440. PubMed ID: 38229567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subgroup-Enriched Pathways and Kinase Signatures in Medulloblastoma Patient-Derived Xenografts.
    Leskoske KL; Garcia-Mansfield K; Sharma R; Krishnan A; Rusert JM; Mesirov JP; Wechsler-Reya RJ; Pirrotte P
    J Proteome Res; 2022 Sep; 21(9):2124-2136. PubMed ID: 35977718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.
    Kresbach C; Holst L; Schoof M; Leven T; Göbel C; Neyazi S; Tischendorf J; Loose C; Wrzeszcz A; Yorgan T; Rutkowski S; Schüller U
    Neuro Oncol; 2024 Apr; 26(4):609-622. PubMed ID: 37767814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma.
    Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H
    Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting BRD4 and PI3K signaling pathways for the treatment of medulloblastoma.
    Sethi B; Kumar V; Jayasinghe TD; Dong Y; Ronning DR; Zhong HA; Coulter DW; Mahato RI
    J Control Release; 2023 Feb; 354():80-90. PubMed ID: 36599397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis.
    Han B; Wang Y; Yue S; Zhang YH; Kuang L; Gao BB; Wang Y; Zhang Z; Pu X; Wang XF; Hui CC; Yu TT; Liu C; Cheng SY
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38358805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma.
    Conti V; Cominelli M; Pieri V; Gallotti AL; Pagano I; Zanella M; Mazzoleni S; Pivetta F; Patanè M; Scotti GM; Piras IS; Pollo B; Falini A; Zippo A; Castellano A; Maestro R; Poliani PL; Galli R
    JCI Insight; 2021 Dec; 6(23):. PubMed ID: 34673573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating native GABA
    Kallay L; Keskin H; Ross A; Rupji M; Moody OA; Wang X; Li G; Ahmed T; Rashid F; Stephen MR; Cottrill KA; Nuckols TA; Xu M; Martinson DE; Tranghese F; Pei Y; Cook JM; Kowalski J; Taylor MD; Jenkins A; Pomeranz Krummel DA; Sengupta S
    J Neurooncol; 2019 May; 142(3):411-422. PubMed ID: 30725256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression.
    Wolin AR; Vincent MY; Hotz T; Purdy SC; Rosenbaum SR; Hughes CJ; Hsu JY; Oliphant MUJ; Armstrong B; Wessells V; Varella-Garcia M; Galbraith MD; Pierce A; Wang D; Venkataraman S; Danis E; Veo B; Serkova N; Espinosa JM; Gustafson DL; Vibhakar R; Ford HL
    Neuro Oncol; 2023 Dec; 25(12):2287-2301. PubMed ID: 37486991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma Cells: Involvement of HDACs and EGFR.
    Laschuk Herlinger A; Lovatto Michaelsen G; Sinigaglia M; Fratini L; Nogueira Debom G; Braganhol E; Brunetto de Farias C; Lunardi Brunetto A; Tesainer Brunetto A; da Cunha Jaeger M; Roesler R
    Neuromolecular Med; 2023 Dec; 25(4):573-585. PubMed ID: 37740824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma.
    Maximov V; Chen Z; Wei Y; Robinson MH; Herting CJ; Shanmugam NS; Rudneva VA; Goldsmith KC; MacDonald TJ; Northcott PA; Hambardzumyan D; Kenney AM
    Nat Commun; 2019 Jun; 10(1):2410. PubMed ID: 31160587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics.
    Yang H; Li M; Deng Y; Wen H; Luo M; Zhang W
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23233. PubMed ID: 38607297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.